Related references
Note: Only part of the references are listed.10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022
DIABETES CARE (2022)
Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure A Secondary Analysis of the TRIUMPH Randomized Clinical Trial
Sonali R. Gnanenthiran et al.
JAMA CARDIOLOGY (2022)
Efficacy and Tolerability of Telmisartan/Amlodipine plus Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study
Ki-Chul Sung et al.
CLINICAL THERAPEUTICS (2018)
2017 ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/N MA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka A Randomized Clinical Trial
Ruth Webster et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
Caroline S. Fox et al.
DIABETES CARE (2015)
Lowering blood pressure in diabetes
Seema Kang
LANCET DIABETES & ENDOCRINOLOGY (2015)
Blood Pressure Lowering in Type 2 Diabetes A Systematic Review and Meta-analysis
Connor A. Emdin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Endothelial Dysfunction in Diabetes and Hypertension: Cross Talk in RAS, BMP4, and ROS-dependent COX-2-derived Prostanoids
Wing Tak Wong et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2013)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
M. R. Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
A. Patel et al.
LANCET (2007)
Association of sleep apnea and type II diabetes - A population-based study
KJ Reichmuth et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Diabetes and hypertension, the deadly duet: Importance, therapeutic strategy, and selection of drug therapy
PC Deedwania
CARDIOLOGY CLINICS (2005)
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes
G Giacchetti et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2005)
Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension
RJ Huggett et al.
CIRCULATION (2003)
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
MR Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Influence of diabetes and type of hypertension on response to antihypertensive treatment
MJ Brown et al.
HYPERTENSION (2000)
Share Paper
